Skip to main content
Loading
Michael Schrader

Michael Schrader

CEO, Vaxess Technologies
United States
Michael Schrader is the CEO of Vaxess, a clinical-stage company bringing healthcare out of the clinic and into patients’ lives with the MIMIX patch platform. The company has a pipeline of vaccines and biologics under development, including the first influenza vaccine intended for home-based administration. He also serves as an Expert-In-Residence at the Harvard Office of Technology Development and as a Key Advisory Board Member for the Harvard Blavatnik Fellowship program. Prior to Vaxess, Michael spent time at Google and Honda where he helped bring a range of products to market and earned more than fifteen patents. Michael received his B.S. in Mechanical Engineering from Purdue University and his M.B.A. from Harvard.
Sessions

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS